Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • Monday
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to KnowZacks Investment Research • 10/21/26
Novavax (NVAX) Stock Declines While Market Improves: Some Information for InvestorsZacks Investment Research • 10/19/26
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady24/7 Wall Street • 10/16/26
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • 10/13/26
Vaccine Stocks Rally on Reports of U.S.-led Push for Cancer VaccinesZacks Investment Research • 10/12/26
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 10/09/26
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher24/7 Wall Street • 10/06/26
Novavax (NVAX) Surges 20.1%: Is This an Indication of Further Gains?Zacks Investment Research • 10/06/26
Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up24/7 Wall Street • 10/05/26
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 09/28/26
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to KnowZacks Investment Research • 09/18/26
Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher24/7 Wall Street • 09/17/26
Novavax, Inc. (NVAX) Presents at Citigroup's Biopharma Back to School Summit 2026 TranscriptSeeking Alpha • 09/10/26
Novavax Highlights Matrix-M Licensing Push, Oncology Ambitions at Cantor ConferenceMarketBeat • 09/10/26